QC
FLGT icon

Quent Capital’s Fulgent Genetics FLGT Stock Holding History

Quent Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-66
Closed -$1.76K – 1340
2023
Q3 		$1.76K Hold
66
– – ﹤0.01% 1193
2023
Q2 		$2.43K Hold
66
– – ﹤0.01% 1165
2023
Q1 		$2.05K Buy
66
+1
+2% +$32 ﹤0.01% 1163
2022
Q4 		$1.96K Hold
65
– – ﹤0.01% 1150
2022
Q3 		$3K Sell
65
-1
-2% -$50 ﹤0.01% 1039
2022
Q2 		$4K Buy
66
+1
+2% +$55 ﹤0.01% 970
2022
Q1 		$4K Hold
65
– – ﹤0.01% 1068
2021
Q4 		$7K Buy
+65
New +$5.71K ﹤0.01% 869

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quent Capital's FLGT Position: Q4 2023 in Review

Quent Capital sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 66 shares — an estimated $1.76K sold.

Quent Capital first reported a position in FLGT in Q4 2021 and held it in 8 quarters. The position peaked at $7K in Q4 2021. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Quent Capital reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Quent Capital sold 66 Fulgent Genetics shares in Q4 2023, an estimated $1.76K.
  • Quent Capital first reported a position in Fulgent Genetics in Q4 2021 and held it in 8 quarters.
  • Quent Capital's Fulgent Genetics position peaked at $7K in Q4 2021.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Quent Capital's 13F filing for Q4 2023, filed 19 Jan 2024.